Download presentation
Presentation is loading. Please wait.
Published byKatherine Sims Modified over 6 years ago
1
Therapy of Sclerodermatous Chronic Graft-Versus-Host Disease with Mammalian Target of Rapamycin Inhibitors Zuzana Jedlickova, Irina Burlakova, Gesine Bug, Herrad Baurmann, Rainer Schwerdtfeger, Michael Schleuning Biology of Blood and Marrow Transplantation Volume 17, Issue 5, Pages (May 2011) DOI: /j.bbmt Copyright © 2011 American Society for Blood and Marrow Transplantation Terms and Conditions
2
Figure 1 Kaplan-Meier estimates of overall survival since initiation of mTOR-I therapy comparing sirolimus and everolimus. Biology of Blood and Marrow Transplantation , DOI: ( /j.bbmt ) Copyright © 2011 American Society for Blood and Marrow Transplantation Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com Inc.
All rights reserved.